Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

Why I’d ditch buy-to-let property and buy these 2 FTSE 100 growth shares today

I think that these two FTSE 100 (INDEXFTSE:UKX) shares could offer long-term growth potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With house prices being close to record levels when compared to average incomes, the capital growth potential of buy-to-let investments may be somewhat limited.

By contrast, the FTSE 100 appears to offer significant long-term growth prospects. A number of its members trade on fair valuations, and are expected to post improving financial performances as they deliver on their strategies.

Here are two prime examples of such companies. Buying them now could be a worthwhile move, since they may outperform buy-to-let investments in the coming years.

AstraZeneca

The recent third-quarter update from AstraZeneca (LSE: AZN) highlighted the rapid pace of growth that the FTSE 100 pharmaceutical company is experiencing. Its core earnings increased by 36% in the quarter compared to the same period of the prior year. This highlights the success of its strategy, with the company’s pipeline suggesting that a rapid rate of growth may be maintained over the long run.

As a result of its improving financial performance, the stock now trades on a price-to-earnings (P/E) ratio of around 27. While this may seem to be high, the stock is forecast to post a rise in its bottom line of 20% next year. This could justify its current valuation – especially since its balance sheet and cash flow provide the financial firepower it needs to maintain a high level of investment in its pipeline.

AstraZeneca’s defensive characteristics may appeal to investors in 2020. The company’s financial performance is less dependent on the wider economy than is the case for many of its FTSE 100 peers. As such, now could be the right time to buy a slice of it, with its current growth strategy set to lead to an improving share price performance.

Burberry

Another FTSE 100 share that has a solid growth strategy is Burberry (LSE: BRBY). The premium fashion business has changed its senior management team in the last few years, and is embarking on major strategy shifts that seem to be working well.

For example, it is working to move even more upmarket, is cutting costs, has launched a wide range of new products under its new creative head that are proving popular with consumers, and is seeking to boost its sales through the use of social media and influencers. Its focus on its highest-end  luxury products also involves store closures and store upgrades, all of it potentially leading to improving financial performance.

Although Burberry’s share price now trades on a P/E ratio of 24, it is forecast to produce a 10% rise in net profit next year. Beyond this, its exposure to fast-growing consumer markets across Asia could strengthen its investment appeal. Therefore, while there may be cheaper stocks available in the FTSE 100, the company’s financial prospects and its economic moat that is derived from a high degree of brand loyalty could lead to significant capital growth in the coming years.

Peter Stephens owns shares of AstraZeneca. The Motley Fool UK has recommended AstraZeneca and Burberry. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

The BP share price could face a brutal reckoning in 2026

Harvey Jones is worried about the outlook for the BP share price, as the global economy struggles and experts warn…

Read more »

Midnight is celebrated along the River Thames in London with a spectacular and colourful firework display.
Investing Articles

How on earth did Lloyds shares explode 75% in 2025?

Harvey Jones has been pleasantly surprised by the blistering performance of Lloyds shares over the last year or two. Will…

Read more »

Group of four young adults toasting with Flying Horse cans in Brazil
Investing Articles

Down 56% with a 4.8% yield and P/E of 13 – are Diageo shares a generational bargain?

When Harvey Jones bought Diageo shares he never dreamed they'd perform this badly. Now he's wondering if they're just too…

Read more »

Number three written on white chat bubble on blue background
Investing Articles

Could these 3 holdings in my Stocks and Shares ISA really increase in value by 25% in 2026?

James Beard’s been looking at the 12-month share price forecasts for some of the positions in his Stocks and Shares…

Read more »

National Grid engineers at a substation
Investing Articles

2 reasons I‘m not touching National Grid shares with a bargepole!

Many private investors like the passive income prospects they see in National Grid shares. So why does our writer not…

Read more »

Number 5 foil balloon and gold confetti on black.
Investing Articles

£10,000 invested in Greggs shares 5 years ago would have generated this much in dividends…

Those who invested in Greggs shares five years ago have seen little share price growth. However, the dividends have been…

Read more »

Rolls-Royce Hydrogen Test Rig at Loughborough University
Growth Shares

Here is the Rolls-Royce share price performance for 2023, 2024, and 2025

Where will the Rolls-Royce share price be at the end of 2026? Looking at previous years might help us find…

Read more »

Investing Articles

This FTSE 250 stock could rocket 49%, say brokers

Ben McPoland takes a closer look at a market-leading FTSE 250 company that generates plenty of cash and has begun…

Read more »